Victorian pharmacist Dr Kate Wang named Early Career Pharmacist of the year

1 August 2025

 

The Pharmaceutical Society of Australia (PSA) is proud to announce Dr Kate Wang MPS as the 2025 PSA Symbion Early Career Pharmacist of the Year.

 

Dr Wang MPS is driving innovation and expansion of the pharmacy profession, particularly in reducing the risk of medicine harm in aged care. A Senior Lecturer in pharmacy at RMIT, Dr Wang is passionate about education future pharmacists and expanding the profession’s scope of practice.

 

She is also the chief investigator and stakeholder liaison officer for a nation-wide project integrating pharmacists into aged care, paving the way for more pharmacists to make a real difference to patients at risk of medicine harm. Dr Wang is also currently investigating the utilisation of e-prescriptions from the perspectives of consumers as well as pharmacists.

 

Kate’s influence extends internationally, collaborating with international partners in New Zealand, Korea, and China to explore the impact of beliefs and adherence on medicine use in older people and expand the roles of pharmacists in aged care.

 

PSA National President Associate Professor Fei Sim FPS congratulated Dr Wang, saying: “Kate is an outstanding pharmacist who is leaving her mark on the pharmacy profession, particularly through her work in improving Quality Use of Medicines and medicine safety in aged care.”

 

“Pharmacists are often defined by the positive relationships we have with our patients and our communities, and Jackie has demonstrated just how important they are both inside the pharmacy and out.

 

“On behalf of the pharmacy profession, I congratulate Dr Wang on being named the 2025 PSA Symbion Early Career Pharmacist of the Year.”

 

PSA thanks Symbion for their continued support of the national PSA Excellence Awards.

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au